Study to Assess a Booster Dose of GBS-NN/NN2 Vaccine

Clinical trial NCT05005247 · COMPLETED

Trial details

NCT number: NCT05005247
Sponsor: Minervax ApS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Group B Streptococcus Infection

Start date: 2021-08-17
Primary completion: 2022-08-05
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.